The development of next-generation drug-based approaches to treat inner ear disorders is gaining momentum, with multiple INDs approved in the last six months and big pharma making plays to acquire innovative biotechs working on hearing loss.
The 3rd Inner Ear Disorder Therapeutics Summit is bringing together the community to collectively accelerate the development of drug-based approaches, sharing case studies and data-driven insights into optimising preclinical programmes and designing translational studies to ultimately validate clinically relevant targets.
This is your opportunity to join more than 100 of your peers to learn about the latest advancements and key insights from industry leaders, such as:
- Exploring recent innovations and potential breakthroughs in the inner ear space with industry leaders Sensorion, Akouos, and Decibel Therapeutics and gain valuable insights into their delivery methods and clinical trial development
- Delving into the key learnings from former Frequency and Otonomy employees to navigate the complex topics of clinical trial design, clinical endpoints, and working with regulatory bodies to safeguard your drug development pipeline
- Hearing directly from investors and grant providers to gain crucial insights into the key considerations made when investing in the inner ear disorders space. Actively engage with investors, ask questions, and foster an open dialogue
Want to learn more? Download our event guide to see the exciting lineup of sessions and our full speaker faculty.
Don’t miss this opportunity to unite with leading experts in the space and enhance your expertise at the only industry-led event focused specifically on inner ear disorders therapeutics.
Register now using the discount code: ENT3375410 and receive an additional 10% off your full three-day pass.
